News

Stroke Tied to Withdrawal of Antithrombotics


 

SAN FRANCISCO — As many as 26,500 ischemic strokes occurring in the United States each year may be associated with patient withdrawal from antithrombotic and antiplatelet medications, according to a study presented at the International Stroke Conference.

Among 2,082 patients in the Cincinnati area who had 2,191 ischemic strokes in 2005, 84 (3.8%) of the strokes occurred in patients who had stopped their medications within 60 days. The first 7 days after withdrawal of antiplatelet or antithrombotic medication appeared to be the most dangerous time, Dr. Jordan Bonomo of the University of Cincinnati reported.

A total of 182 strokes occurred in warfarin patients. Of the 58 strokes that occurred in those who went off warfarin, 31 were within 7 days of withdrawal, 12 at 8–14 days, 8 at 15–30 days, and 7 at 31–60 days.

Similarly, 896 patients had been taking aspirin around the time of their stroke. Of these, 44 had discontinued aspirin; 24 of the strokes occurred within 7 days after halting aspirin therapy, 7 at 8–14 days, 11 at 15–30 days, and 2 at 31–60 days.

The investigators found a similar pattern among 228 patients who had been taking clopidogrel around the time of their stroke, 21 of whom had stopped taking the drug—10 strokes occurred within 7 days of discontinuation, 4 at 8–14 days, 5 at 15–30 days, and 2 at 31–60 days.

These results “mandate continued review of guidelines for withdrawal of anticoagulant and antiplatelet medication in the peri-procedural period,” he said.

Dr. Bonomo stated that he had no conflicts of interest. The study was supported by the National Institute of Neurological Disorders and Stroke.

Recommended Reading

Triple Therapy Reduces Restenosis After PCI
MDedge Internal Medicine
Patients Overestimate the Benefits of Elective PCI
MDedge Internal Medicine
Aldosterone Blockers Lower BP in Obese Patients
MDedge Internal Medicine
Drug-Eluting Stents Cut Mortality in Diabetes
MDedge Internal Medicine
At-Home INR Monitoring Safe for Patients on Warfarin
MDedge Internal Medicine
Rosuvastatin Slashed Stroke Risk in JUPITER
MDedge Internal Medicine
Impact of PPIs on Clopidogrel Activity Uncertain
MDedge Internal Medicine
AAA Screen Warranted in Men With TIA or Stroke
MDedge Internal Medicine
Intake of Non-Soy Legumes Tied to Lower Cholesterol
MDedge Internal Medicine
Genetic Factors, PPIs May Alter Effectiveness of Clopidogrel
MDedge Internal Medicine